[LICITANET] - Acquisition of medicines for the Hospital Evangélico de Vila Velha, State Agreement No. 003/2024.

This tender, identified as [LICITANET] and managed by the Hospital Evangélico, involves the acquisition of essential medicines for the Hospital Evangélico de Vila Velha. The procurement is conducted under State Agreement No. 003/2024, indicating a collaborative effort or funding mechanism at the state level. The goal is to ensure a consistent and adequate supply of pharmaceutical products to meet the healthcare demands of patients served by the hospital. The contracting authority is the Hospital Evangélico, located in Vila Velha, Espírito Santo. The tender utilizes the electronic "pregão" (auction) modality, an open-closed bidding process, in compliance with Law 14.133/2021, Article 28, I, for the procurement of common goods. The estimated total value for this acquisition is R$ 68,708.36. The process number is 006/2026, and the purchase number is 006. Interested suppliers are invited to submit their proposals, with the opening scheduled for March 3, 2026, at 07:44, and the closing deadline on March 16, 2026, at 09:15. This procurement is critical for maintaining the operational capacity and quality of care provided by the Hospital Evangélico de Vila Velha.

This is a supplies contract in the health and medical services, legal services and information and communication technology sectors, with a focus on Hospitals and Pharmaceuticals. Located in Brazil, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of BRL 68,708.

Published through Brazil PNCP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.